Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.38%
median of 786 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Contineum Therapeutics, Inc.
Market Cap
$471.02M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$468.74M
Gross Margin
87.96%
TTM Avg
85.84%
3Y Avg
84.92%
5Y Avg
81.46%
Market Cap
$472.03M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$475.60M
Gross Margin
52.05%
TTM Avg
54.84%
3Y Avg
54.67%
5Y Avg
54.23%
Market Cap
$486.35M
Gross Margin
74.83%
TTM Avg
73.30%
3Y Avg
73.96%
5Y Avg
75.53%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | $471.02M | 0.00% | 0.00% | 0.00% | N/A |
| Sight Sciences, Inc. (SGHT)vs › | $468.74M | 87.96% | 85.84% | 84.92% | 81.46% |
| Kamada Ltd. (KMDA)vs › | $469.63M | 40.82% | 42.91% | 40.22% | 37.63% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.03M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cerus Corporation (CERS)vs › | $475.60M | 52.05% | 54.84% | 54.67% | 54.23% |
| Arvinas, Inc. (ARVN)vs › | $477.13M | 96.43% | 99.01% | 99.50% | 99.67% |
| NRC Health (NRC)vs › | $459.39M | 56.33% | 58.27% | 60.30% | 61.48% |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.35M | 74.83% | 73.30% | 73.96% | 75.53% |
| Evolus, Inc. (EOLS)vs › | $487.98M | 66.25% | 66.66% | 65.82% | 64.54% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $448.58M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 99.92% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
